Chronic neurosteroid treatment produces functional heterologous uncoupling at the gamma-aminobutyric acid type A/benzodiazepine receptor complex in mammalian cortical neurons

Mol Pharmacol. 1995 Mar;47(3):603-10.

Abstract

We have investigated the effects of chronic treatment with the neurosteroid 5 alpha-pregnan-3 alpha-ol-20-one (5 alpha 3 alpha) on the gamma-aminobutyric acid (GABA)A receptor complex in cultured mammalian cortical neurons. Chronic 5 alpha 3 alpha treatment (up to 2 microM, 5 days) did not produce any changes in the morphological appearance or the cell protein content of cortical neurons. The basal binding of [3H]flunitrazepam, [3H]Ro15-1788, and [3H]Ro15-4513 was not altered after the chronic treatment. Chronic 5 alpha 3 alpha treatment did not alter the Kd or Bmax values of [3H]flunitrazepam binding to intact cortical neurons. However, chronic 5 alpha 3 alpha treatment produced uncoupling between GABA, barbiturate, and neurosteroid sites and the benzodiazepine site. The EC50 values of these ligands were not significantly altered; however, their Emax values were decreased after chronic 5 alpha 3 alpha treatment. The 5 alpha 3 alpha-induced uncoupling was time and concentration dependent. The binding of [3H]GABA and t-[35S]butylbicyclophosphorothionate was also decreased after chronic 5 alpha 3 alpha treatment. Chronic 5 alpha 3 alpha treatment decreased the Bmax of the low affinity GABAA receptor sites, without affecting the high affinity sites, and decreased the Bmax of t-butylbicyclophosphorothionate binding sites. The EC50 value for GABA-induced 36Cl- influx was not altered, whereas the Emax value was decreased after chronic 5 alpha 3 alpha treatment. Furthermore, the 5 alpha 3 alpha-induced uncoupling was reversed by concomitant exposure of the cortical neurons to 5 alpha-pregnan-3 beta-ol-20-one or R5135, suggesting an involvement of the neurosteroid and GABA recognition sites in the observed uncoupling. Taken together, these results suggest that chronic 5 alpha 3 alpha treatment produces heterologous uncoupling at the GABAA receptor complex.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Androstanes / pharmacology
  • Animals
  • Azasteroids / pharmacology
  • Bridged Bicyclo Compounds / metabolism
  • Bridged Bicyclo Compounds / pharmacology
  • Bridged Bicyclo Compounds, Heterocyclic*
  • Cells, Cultured
  • Cerebral Cortex / drug effects*
  • Cerebral Cortex / metabolism
  • Cerebral Cortex / ultrastructure*
  • Chlorides / pharmacokinetics
  • Chlorine
  • Convulsants / metabolism
  • Convulsants / pharmacology
  • Drug Interactions
  • GABA Antagonists / pharmacology
  • Kinetics
  • Mice
  • Mice, Inbred C57BL
  • Neurons / drug effects*
  • Neurons / metabolism
  • Neurons / ultrastructure*
  • Pregnanolone / antagonists & inhibitors
  • Pregnanolone / pharmacology*
  • Radioisotopes
  • Radioligand Assay
  • Receptors, GABA-A / drug effects*
  • Receptors, GABA-A / metabolism*
  • Receptors, GABA-A / physiology
  • Sulfur Radioisotopes
  • Time Factors
  • Tritium
  • gamma-Aminobutyric Acid / metabolism
  • gamma-Aminobutyric Acid / pharmacology

Substances

  • Androstanes
  • Azasteroids
  • Bridged Bicyclo Compounds
  • Bridged Bicyclo Compounds, Heterocyclic
  • Chlorides
  • Convulsants
  • GABA Antagonists
  • Radioisotopes
  • Receptors, GABA-A
  • Sulfur Radioisotopes
  • Tritium
  • Chlorine
  • gamma-Aminobutyric Acid
  • tert-butylbicyclophosphorothionate
  • Pregnanolone
  • RU 5135